Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome

Journal: Journal of Clinical Investigation

Published: 2019-10-01

DOI: 10.1172/jci127046

Affiliations: 5

Authors: 9

Go to article
Institutions Share
Department of Medical Oncology and Therapeutics Research, City of Hope, United States of America (USA) 0.44
Department of Immuno-Oncology, City of Hope, United States of America (USA) 0.33
Department of Computational Quantitative Medicine, City of Hope, United States of America (USA) 0.11
Comprehensive Cancer Center, City of Hope, United States of America (USA) 0.06
Division of Biostatistics, City of Hope, United States of America (USA) 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER